Related Experiment Video

Updated: May 12, 2026

Preparation and Evaluation of 99mTc-labeled Tridentate Chelates for Pre-targeting Using Bioorthogonal Chemistry
10:54

Preparation and Evaluation of 99mTc-labeled Tridentate Chelates for Pre-targeting Using Bioorthogonal Chemistry

Published on: February 4, 2017

Effects of chelator modifications on (68)Ga-labeled [Tyr (3)]octreotide conjugates

Mai Lin1, Michael J Welch, Suzanne E Lapi

  • 1Mallinckrodt Institute of Radiology, Washington University School of Medicine, Campus Box.8225, 510 South Kingshighway Blvd, St. Louis, MO, 63110, USA.

Molecular Imaging and Biology
|March 27, 2013
PubMed
Abstract

Insights

Modifying chelators on Gallium-68 (68Ga)-labeled peptide conjugates impacts their performance. An optimal charge exists for these imaging agents, influencing tumor uptake and binding affinity for better cancer diagnostics.

Area of Science:

  • Radiochemistry
  • Nuclear Medicine
  • Oncology

Background:

  • Somatostatin receptors (SSTR) are key targets for cancer imaging.
  • (68)Ga-DOTATOC PET imaging is established for SSTR-expressing tumors.
  • Peptide-based imaging agents offer targeted diagnostic potential.

Purpose of the Study:

  • To investigate how chelator modifications and charge affect (68)Ga-labeled peptide conjugates.
  • To evaluate the impact of NOTA-based chelator variations on SSTR-targeting agents.
  • To compare novel conjugates with (68)Ga-DOTATOC for PET imaging.

Main Methods:

  • Synthesis of [Tyr(3)]octreotide conjugates with varying NOTA-based chelators (2-5 carboxylates).
  • In vitro assessment of binding affinity and internalization.
  • In vivo evaluation of tumor uptake in preclinical models.
  • Comparison with (68)Ga-DOTATOC and other controls.

Main Results:

  • Increased carboxylates (beyond three) generally reduced binding affinity and internalization.
  • Tumor uptake of conjugates with four and five carboxylates was lower than controls at 2 hours post-injection.
  • An optimal charge balance appears crucial for effective tumor targeting.
  • (68)Ga-1 (three carboxylates) showed comparable results to (68)Ga-DOTATOC.

Conclusions:

  • Chelator modifications significantly alter the pharmacokinetic properties of (68)Ga-labeled peptide conjugates.
  • These findings are critical for the rational design of future peptide-based imaging agents.
  • Optimization of chelator charge is essential for enhancing diagnostic efficacy.

More Related Videos

Investigations on the Ga(III) Complex of EOB-DTPA and Its 68Ga Radiolabeled Analogue11:22

Investigations on the Ga(III) Complex of EOB-DTPA and Its 68Ga Radiolabeled Analogue

Published on: August 17, 2016

Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates08:47

Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates

Published on: March 6, 2019

Related Concept Videos

Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Complexation Equilibria: The Chelate Effect01:19

Complexation Equilibria: The Chelate Effect

In complexation reactions, metal atoms or cations interact with ligands to form donor-acceptor adducts called metal complexes. Ligands that bind through one donor site are monodentate, ligands with two donor sites are bidentate, and those with more than two donor sites are polydentate ligands. For example, ethylene diamine is a bidentate ligand that binds through two nitrogen donor atoms, forming a five-membered ring. EDTA is a polydentate ligand that binds through four oxygen and two nitrogen...
Drug Metabolism: Phase II Reactions01:14

Drug Metabolism: Phase II Reactions

Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...